John L. Roberts
Papers
1
Total Citations
26
H-Index
1
About
John L. Roberts is a leading figure in glycobiology, with a primary focus on the enzyme heparanase and its roles in cancer metastasis and inflammation. His most cited work, "High-throughput methods for measuring heparanase activity and screening potential antimetastatic and anti-inflammatory agents" (2004, 26 citations), introduced a pivotal methodological breakthrough that enabled rapid, large-scale screening of heparanase inhibitors. This contribution has been instrumental in accelerating the discovery of therapeutic candidates aimed at blocking tumor spread and reducing inflammatory responses. Roberts’ research bridges fundamental biochemistry and translational medicine, providing tools that have been widely adopted by labs investigating extracellular matrix remodeling. His work has not only advanced understanding of heparanase’s mechanistic functions but also laid the groundwork for developing targeted antimetastatic and anti-inflammatory drugs. Through these efforts, Roberts has established himself as a key innovator in the field, with his high-throughput assays continuing to serve as a cornerstone for both academic research and pharmaceutical development.
Research Focus
Key Achievements
Top Papers
- 1